September 13, 2019
Catalyst backs from offering common stock shares
Catalyst Pharmaceuticals, said Friday it will not conclude the offering of shares of its common stock announced on Wednesday, September…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Catalyst Pharmaceuticals
July 10, 2019
Catalyst Launches New Multi-solution CRO Powered by the Medidata Rave Clinical Cloud™
Catalyst adopts unified platform approach to immediately offer impactful and competitive services for biopharmaceutical companies New full service offerings adopt…
January 4, 2019
Catalyst Pharmaceuticals’ Firdapse tablets meet endpoints in Phase II trial
Catalyst Pharmaceuticals Phase IIb clinical trial for Firdapse tablets, published in SAGE Open Medicine, for the treatment of MuSK antibody positive Myasthenia Gravis (MuSK-MG), has given evidence that amifampridine phosphate was safe and effective in treating MuSK-MG patients.
May 11, 2017
Catalyst Pharmaceuticals reports $4.9M loss for Q1 2017
Catalyst Pharmaceuticals has reported a GAAP net loss of $4.9 million for first quarter of 2017, compared to a GAAP net loss of $5,4 for the same period in 2016.
March 14, 2017
Biocept, Catalyst Pharmaceuticals provide liquid biopsy testing for small cell lung cancer for patients with LEMS
Biocept and Catalyst Pharmaceuticals announced a partnership which will provide Biocept’s Target Selector platform to screen patients diagnosed with LEMS for early onset or recurrence of small cell lung cancer (SCLC).
December 15, 2016
Catalyst Pharmaceuticals begin testing its orphan drug on first patients
Catalyst Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, has announced…
November 10, 2016
Catalyst Pharmaceuticals finishes Q3 2016 with net loss
Catalyst Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating …